U.S. Department of Health and Human Services

Digestive Diseases Research Core Centers

The Digestive Diseases Research Core Centers program provides a mechanism for funding shared resources (i.e., core facilities).  Through these Centers, the NIDDK aims to integrate, coordinate, and foster interdisciplinary cooperation between groups of established investigators that conduct high-quality research on digestive diseases.  An existing base of outstanding digestive disease-related research is a prerequisite for the establishment of a Center.  Research in these Centers focuses on:  liver diseases; gastrointestinal motility, absorption and secretion processes; inflammatory bowel disease; structure/function relationships in the gastrointestinal tract; neuropeptides and gut hormones; and gastrointestinal membrane receptors.​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

 

 NIDDK Staff

 
Peter Perrin Ph.D.Gastrointestinal Host-Microbial Interactions, Basic Mucosal Immunology and Inflammation

Funding Mechanisms

NIDDK funds Digestive Diseases Centers under the P30 funding mechanism

Centers Sites

There are currently 17 Digestive Diseases Research Core Centers funded by NIDDK.

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
11/25/2016Limited Competition: Research Resource for Human Organs and Tissues (U42) (Summary) RFA-OD-17-001
11/23/2016NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3) (Summary) RFA-RM-16-019
10/27/2016NIDDK Exploratory Clinical Trials for Small Business (R44) (Summary) PAR-17-034
10/19/2016Addressing Health Disparities in NIDDK Diseases (R01) (Summary) PA-17-021
10/11/2016Microphysiological Systems (MPS) for Disease Modeling and Efficacy Testing (UG3/UH3) (Summary) RFA-TR-16-017
View More Funding Opportunities

The resources listed below include reagents, data, protocols, etc. If you would like to utilize any of these resources, contact the person associated with the resource.

 

 Research Resources

 
Resource NameDescription
Acute Liver Failure Study Group
The Acute Liver Failure Study Group is collecting biosamples and information on the natural history, causes and outcomes of Acute Liver Failure in the United States. In addition to the database, a clinical trial conducted to test whether the drug…
Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction

The EPISOD study is a prospective, double-blind, randomized, sham-controlled, multi-center clinical trial. The EPISOD study enrolls subjects who have received a prior cholecystectomy and are diagnosed with the clinical syndrome of Sphincter of Oddi…

Inflammatory Bowel Disease Genetic Consortium

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) consists of investigators from seven sites in the U.S. and Canada, who have recruited a large sample of inflammatory bowel disease patients, their relatives, and control subjects. All…

Action to Control Cardiovascular Disease Risk in Diabetes Follow-up Study
ACCORDION (sponsored by NHLBI) is a prospective, observational follow-up study of at least 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.  Treatment in ACCORD ended in 2009 and…
Diabetic Complications Consortium
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to foster communication and collaboration between investigator communities involved in complications research.  Toward this goal, DiaComp: (1) sponsors annual meetings in…

View Additional Research Resources

 

 NIDDK Active Trials in Digestive Disease

 
View related clinical trials from ClinicalTrials.gov.

 

 Related Study Sections

 
​​Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.

NIH Common Fund

Learn about current projects and view funding opportunities sponsored by the​ ​​NIH Common Fund.​